Keros Therapeutics (KROS) Earnings (2019 - 2026)
Keros Therapeutics (KROS) earnings from Mar 31, 2019 to Mar 31, 2026. The TTM Keros Therapeutics (KROS) earnings is -$85M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Keros Therapeutics (KROS) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -9.87% |
| 5 Years TTM | +11.52% |
| All Time TTM | +26.24% |
Annual Earnings change of Keros Therapeutics (KROS)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$24M | -127.25% |
| 2025 | $87M | -146.44% |
| 2024 | -$187M | +22.46% |
| 2023 | -$153M | +46.15% |
| 2022 | -$105M | +78.21% |
| 2021 | -$59M | +29.50% |
| 2020 | -$45M | +267.59% |
| 2019 | -$12M | N/A |
Comparison Keros Therapeutics (KROS) five years earnings CAGR with competitors
Keros Therapeutics (KROS) five years earnings CAGR is 11.52%.